Recognition of respiratory syncytial virus fusion protein by mouse cytotoxic T cell clones and a human cytotoxic T cell line

Clicks: 444
ID: 116160
1989
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #9 of 14 articles by views in the journal of general virology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Two mouse cytotoxic T cell (Tc) clones, D5 and H11a, with specificity for the respiratory syncytial virus (RSV) fusion protein (F) were derived from BALB/c mice primed intranasally (i.n.) with RSV (A2 strain). These clones possessed essentially the same characteristics, and only clone H11a is descri …
Reference Key
mj1989therecognition Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Cannon MJ;Bangham CR;;
Journal the journal of general virology
Year 1989
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/2471784
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE Mice animals humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't cell line Inbred BALB C respiratory syncytial viruses / immunology* cross reactions viral fusion proteins / immunology* t-lymphocytes cytotoxic / immunology* epitopes c r bangham m j cannon clone cells pmid:2471784 doi:10.1099/0022-1317-70-1-79 specific pathogen-free organisms

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.